About
BrightGene Bio-medical technology Co.,Ltd., is a leading Chinese biopharmaceutical company in small molecules and nucleotide drugs areas. Advised by China-based venture capital fund Laurel Venture Capital, BrightGene invests in all stage therapeutics and innovations.
Position in the VCSift Database
- • 4,609 investors in VCSift focus on the biotech sector.
- • 118 investors are based in Suzhou, Jiangsu, China.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- biotech
- Location
- Suzhou, China
Contact Information
linkedin.com/in/••••••••
Find more investors like BrightGene
Search Investors